Tullis manages a family of private equity funds, each focused exclusively on healthcare. The firm was founded in 1986 by Jim Tullis, a leading healthcare investment banker and 14-time Institutional Investor All-Star. Under his leadership, the Tullis family of funds has been investing successfully and exclusively in privately-held healthcare companies through several funds for over 30 years.
Considered a pioneer in healthcare-focused venture and growth capital, the team invests in all major areas of the healthcare industry. The team combines extensive operating and clinical experience, in the US and globally, with a strong history of successful healthcare private equity investing.
Tullis provides equity and equity-related capital to small and emerging healthcare companies. Tullis focuses on companies that have already established operations or have completed a substantial portion of their development process for new products, technologies and services. Many Tullis companies have generated meaningful revenue and require capital in order to reach value-enhancing milestones in a defined two- to four-year period. Others are research & development stage medical companies which have passed key milestones, but require additional capital to achieve commercial status.
Healthcare is a unique and specialized industry, with characteristics that make it difficult and complex for many investors. Regulatory and product approval requirements are demanding and uncertain in outcome. Science and technology are constantly changing and subject to subtleties; to understand these requires highly specialized medical experience, know-how, and training. The complexities make it essential for successful investors to have extensive specialized medical, business, and policy expertise integrated in their team.
In addition, it is crucial today to recognize the increasing trend towards globalization for healthcare therapeutics and services; we work closely with our portfolio companies to support their successful expansion to new global markets.
Tullis has been a pioneer in healthcare-focused venture and growth capital. The firm has invested with success in all major sub-sectors of the healthcare industry. Tullis has actively evolved and developed through the years to seek out and capitalize on discrete emerging opportunities in key areas of healthcare, and has addressed both broad industry trends and globalization of the sector.
Tullis has expertise and has invested in the following healthcare segments:
- Medical Devices
- Healthcare Services
- Healthcare Infrastructure & Distribution
- Healthcare Information Technology